Skip to main content
Theraclion SA logo

Theraclion SA — Investor Relations & Filings

Ticker · ALTHE ISIN · FR0010120402 LEI · 9695007X7HA7A1GCYD29 PA Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2019-06-13 Capital/Financing Update
Country FR France
Listing PA ALTHE

About Theraclion SA

https://www.theraclion.com/?_ga=2.14878…

Theraclion SA is a medical device company specializing in the development and marketing of non-invasive therapeutic solutions using High-Intensity Focused Ultrasound (HIFU). The company's technology, known as echotherapy, provides a non-surgical alternative for tissue ablation. Its flagship product, SONOVEIN®, is a robotic solution for the non-invasive treatment of varicose veins. The system uses external ultrasound beams to ablate the target vein without incisions, catheters, or sedation, allowing for immediate patient recovery. Theraclion also developed ECHOPULSE®, a system for the treatment of thyroid nodules and breast fibroadenomas. The company's core focus is on providing precise, non-invasive treatments that reduce risks and recovery time compared to traditional surgical procedures.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Capital/Financing Update Classification · 99% confidence The document is a short press release dated June 13, 2019, confirming that the company Theraclion remains eligible for the PEA-PME investment scheme. It details the criteria met (employee count, revenue/balance sheet size) and provides general company information and contact details. This type of announcement, which communicates a specific corporate status update or regulatory compliance confirmation that doesn't fit into standard financial reports (10-K, IR, ER) or specific transaction reports (DIV, SHA, POS), is best classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if the PEA-PME eligibility is viewed as a financing mechanism update. Given the focus is purely on maintaining eligibility status rather than raising capital or announcing a specific transaction, RNS serves as the most appropriate general regulatory announcement category for non-standard updates. The document length is short (2576 chars), suggesting it is an announcement rather than a comprehensive report.
2019-06-13 French
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document title is "INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL" (Monthly Information Relative to the Total Number of Voting Rights and Shares Comprising the Share Capital), which is a mandatory disclosure under French AMF regulations (Article 223-16). The content explicitly details the total number of shares and voting rights as of a specific date (May 31, 2019). This type of periodic disclosure regarding share capital and voting rights does not fit neatly into the primary categories like 10-K, ER, or IR. It is a specific regulatory update concerning ownership structure and voting power. Among the provided codes, 'MRQ' (Major Shareholding Notification) is the closest fit as it deals with changes in share structure/ownership thresholds, although this specific filing is a mandatory monthly vote count disclosure. However, given the highly specific nature of the content (monthly voting rights count), and the lack of a dedicated code for 'Share Capital/Voting Rights Update', the most appropriate general regulatory category that covers periodic ownership/capital structure changes is 'MRQ' (Major Shareholding Notification), or potentially 'RNS' (Regulatory Filings) as a fallback. Since it is a structured, periodic report on share capital/voting rights, MRQ is a better fit than the general RNS, as it relates directly to ownership structure reporting.
2019-06-05 French
Informations privilégiées / Autres communiqués
Earnings Release Classification · 95% confidence The document is a press release dated May 15, 2019, announcing major commercial achievements (sale of four Echopulse® solutions) and an expansion of insurance reimbursement for echotherapy in Germany. It details business updates, sales figures, and market access progress. This type of announcement, focusing on operational milestones, sales performance, and market developments rather than comprehensive financial statements (like 10-K or IR) or formal regulatory filings, best fits the category for general business updates or press releases that don't fit a more specific financial or governance code. Since it is not a formal earnings release (ER) which usually contains summarized P&L/Balance Sheet figures, nor a full quarterly report (IR), and it is not announcing a dividend (DIV) or management change (MANG), it is most appropriately classified as a general Regulatory Filing (RNS) as a catch-all for significant, non-standardized corporate news, or potentially an Earnings Release (ER) if the context implies this is the primary update for the period, but given the focus on sales milestones and reimbursement, RNS is safer as a general announcement. FY 2019
2019-05-15 French
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release dated May 15, 2019, announcing specific business achievements: four system sales in Germany and major reimbursement/insurance coverage agreements. This content details operational and commercial progress, which is typical of an Earnings Release (ER) or a general business update. Since it is not a full annual report (10-K), a detailed interim report (IR), a transcript (CT), or a specific regulatory filing like a Director's Dealing (DIRS) or Capital Change (CAP), the most appropriate classification is Earnings Release (ER), as it summarizes recent performance highlights and commercial milestones. It is too detailed for a simple Report Publication Announcement (RPA) and contains specific financial/commercial results.
2019-05-15 English
Informations privilégiées / Autres communiqués
Share Issue/Capital Change Classification · 99% confidence The document announces the issuance of warrants (bons de souscription) following the Annual General Meeting (AGM) held on April 19, 2019, related to a multi-tranche financing agreement (up to €11.8M). The core subject is the execution of a financing activity involving the issuance of securities (warrants convertible into shares or obligations convertible into shares) authorized by shareholder resolutions. This directly relates to changes in the company's capital structure and fundraising efforts. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP). Although it mentions the AGM, the primary focus is the subsequent financing execution, not the AGM materials themselves (AGM-R) or the voting results (DVA).
2019-04-29 French
Modalités de mise à disposition des documents préparatoires à l'AG
AGM Information Classification · 98% confidence The document explicitly announces the results of the 'Assemblée générale ordinaire et extraordinaire annuelle' (Annual Ordinary and Extraordinary General Meeting) held on April 19, 2019. It details the resolutions adopted by the shareholders, including the approval of 2018 accounts and changes to the board composition. This content directly corresponds to the purpose of an Annual General Meeting report or announcement. Since it reports the results and actions taken during the meeting, the most appropriate code is AGM-R (AGM Information). The document is relatively short and reports the outcomes, not just announcing a future event, making AGM-R a better fit than RPA or RNS.
2019-04-23 French

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.